ImmuCell
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ImmuCell generated cash of -$4,674,236, which is less than the previous year. Cash used in financing activities reached the amount of $1,751,454 last year. Net change in cash is therefore -$4,812,821.
Cash Flow
| 2014 | 302.36K | -1.53M | -187.16K |
|---|---|---|---|
| 2015 | 2.90M | -4.61M | 2.44M |
| 2016 | -323.90K | -4.42M | 8.32M |
| 2017 | 1.17M | -12.27M | 9.74M |
| 2018 | -373.40K | -1.79M | 889.61K |
| 2019 | 233.51K | -3.40M | 6.94M |
| 2020 | 1.31M | -2.56M | 1.91M |
| 2021 | 954.17K | -1.59M | 3.87M |
| 2022 | -1.54M | -3.96M | 1.11M |
| 2023 | -4.67M | -1.89M | 1.75M |
ICCC Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.79M | 10.18M | 6.94M | 6.29M | 2.52M | 3.79M | 5.15M | 1.57M | 850.02K | 2.27M |
Operating activities | ||||||||||
Net income | -5.77M | -2.49M | -78.29K | -1.02M | -1.29M | -2.32M | -168.14K | 508.44K | 1.21M | -167.15K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 2.48M | 2.46M | 2.34M | 2.26M | 1.52M | 904.43K | 802.37K | 529.26K | 448.92K |
Stock-based compensation expense | 0 | 266.24K | 144.31K | 253.13K | 313.14K | 344.01K | 199.78K | 67.39K | 23.22K | 30.00K |
| Deferred income tax benefit | 0 | 266.24K | 144.31K | 253.13K | 313.14K | 344.01K | 199.78K | 67.39K | 23.22K | 30.00K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 935.62K | -897.42K | -159.63K | -704.86K | 411.72K | -330.30K | -277.52K | 251.18K | -373.88K |
Inventories | 0 | -2.94M | -997.46K | 425.74K | -186.58K | -281.93K | 77.16K | -1.14M | 75.54K | 260.75K |
Accounts payable | 156.99K | 341 | 245.76M | 299.88M | -190.21K | 196.97K | 448.64M | -182.50M | 60.36M | 178.56M |
Cash generated by operating activities | -4.67M | -1.54M | 954.17K | 1.31M | 233.51K | -373.40K | 1.17M | -323.90K | 2.90M | 302.36K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -15.29K | -1.99M | -10.12M | 0 | -249K | -4.96M | -4.45M | -2.98M |
Investments In Property Plant And Equipment | -1.89M | -3.97M | -2.60M | -4.07M | -1.39M | -2.02M | -17.75M | -3.58M | -2.71M | -1.53M |
Acquisitions Net | 0 | 11K | 15.29K | 45.6K | -8.91K | -14.07K | -8.66K | -368.21K | 0 | 0 |
Cash generated by investing activities | -1.89M | -3.96M | -1.59M | -2.56M | -3.40M | -1.79M | -12.27M | -4.42M | -4.61M | -1.53M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 30.67M | 4.23M | 9 | 8.30M | 96.25K | 3.76M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.81M | 1.10M | -768.27K | -9.57M | -1.36M | -398.30K | 5.99M | -135.84K | 2.33M | -190.31K |
Cash used in financing activities | 1.75M | 1.11M | 3.87M | 1.91M | 6.94M | 889.61K | 9.74M | 8.32M | 2.44M | -187.16K |
Net Change In Cash | -4.81M | -4.39M | 3.23M | 656.64K | 3.77M | -1.27M | -1.35M | 3.57M | 723.3K | -1.42M |
Cash at end of period | 978.74K | 5.79M | 10.18M | 6.94M | 6.29M | 2.52M | 3.79M | 5.15M | 1.57M | 850.02K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |